The Study
The Association of Neuropeptide Y with the Presence and Frequency of Ventricular Premature Beats
This study found that people with heart skips (VES) tend to have more of a chemical called NPY in their blood. But it doesn't prove that NPY makes the skips happen — maybe the skips make NPY go up, or something else (like stress) makes both happen. It's like noticing that people who eat a lot of ice cream also get more sunburns — but that doesn't mean ice cream causes sunburns.
Analysis score
Maximum 58 for a case-control study.
Where the score came from
This study looked at a chemical in the blood called NPY to see if it’s linked to extra heartbeats called VES.
Where does this study sit?
Reviews of RCTs (Meta-analyses)
Max 100Randomized Trials
Max 90Reviews of Cohort Studies
Max 85Cohort Studies
Max 72Reviews of Case-Control Studies
Max 63Case-Control Studies
Max 58Cross-Sectional & Case Series
Max 50Expert Opinion
Max 558 / 100
Quality score
Researchers compare people who have a condition (cases) with similar people who do not (controls), looking back in time for differences in exposure. Useful but more prone to bias.
Key takeaways
Summary
Based on the study abstract and findings.
- 1Yes — this suggests a simple blood test could help doctors guess if someone has frequent heart skips without needing long monitoring.
- 2People with extra heartbeats had higher NPY levels (median 70 ng/L) than those without (50 ng/L).
- 3If NPY is above 47.9 ng/L, it correctly identifies VES in 82 out of 100 people.
- 4If NPY is above 79.8 ng/L, it predicts frequent VES (over 15,000/day) in 85 out of 100 people.
Score breakdown, methodology, conflicts of interest, evidence analysis & raw study data
Publication
Journal
Current Cardiology Reviews
Year
2025
Authors
Necip Fazıl Dedeoglu, M. Taşcanov, K. Toprak, Halil Fedai, Asuman Bicer, I. H. Altıparmak, Z. Tanriverdi, R. Demirbağ, I. Koyuncu
Related Content
Claims (6)
Adults with ventricular premature beats have higher levels of neuropeptide Y in their blood than those without this condition. A blood level of neuropeptide Y at or above 47.9 ng/L correctly identifies 82% of people with ventricular premature beats and correctly rules out 81.4% of those without it.
Patients with more than 15,000 extra heartbeats per day have higher levels of neuropeptide Y in their blood than those with fewer extra heartbeats, and a blood neuropeptide Y level of 79.8 ng/L or higher correctly identifies high extra heartbeat frequency in 85.5% of cases and correctly rules it out in 87.3% of cases.
Higher levels of neuropeptide Y in the blood are associated with a small but statistically significant increase in the occurrence of ventricular premature beats, even after accounting for age, gender, and nervous system activity.
Higher levels of neuropeptide Y are associated with lower heart rate variability, indicating reduced parasympathetic nervous system activity in people with ventricular premature beats.
In people without structural heart disease, heart palpitations occur due to an imbalance between the nervous system pathways that speed up and slow down the heart.
Higher low-frequency heart rate variability measurements are consistently linked to a higher occurrence of ventricular premature beats, with each one-unit increase in low-frequency power corresponding to a small but statistically significant rise in risk.
Not medical advice. For informational purposes only. Always consult a qualified healthcare professional before making health decisions.